Argenx and Vertex Pharmaceuticals named BofA top biotech picks for 2026

Investing.com Gold reports: Argenx and Vertex Pharmaceuticals named BofA top biotech picks for 2026. Full body text was unavailable at ingest time, so this brief is based on headline context.